Mineralocorticoid Receptor Antagonism Confers Cardioprotection in Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mineralocorticoid Receptor Antagonism Confers Cardioprotection in Heart Failure

Published:2012-10-27 Issue:1 Volume:10 Page:36-45
ISSN:1546-9530
Container-title:Current Heart Failure Reports
language:en
Short-container-title:Curr Heart Fail Rep

Author:

Seawell Michael R.,Al Darazi Fahed,Farah Victor,Ramanathan Kodangudi B.,Newman Kevin P.,Bhattacharya Syamal K.,Weber Karl T.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Emergency Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11897-012-0120-x.pdf

Reference115 articles.

1. Kamalov G, Bhattacharya SK, Weber KT. Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol. 2010;56:320–8.

2. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–17.

3. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–21.

4. Weber KT. Efficacy of aldosterone receptor antagonism in heart failure: potential mechanisms. Curr Heart Fail Rep. 2004;1:51–6.

5. •• Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11–21. The efficacy of a mineralocorticoid receptor antagonist was evaluated in the EMPHASIS-HF trial, which consisted of patients having mild heart failure symptoms. A reduced risk of death from cardiovascular causes or hospitalization for heart failure was found.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?;Journal of Internal Medicine;2022-02-09

2. Zinc Deficiency and Heart Failure: A Systematic Review of the Current Literature;Journal of Cardiac Failure;2020-02

3. Rationale and Design of the ATHENA-HF Trial;JACC: Heart Failure;2016-09

4. Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification;Nephron Physiology;2014-11-06

5. On the Pleotropic Actions of Mineralocorticoids;Nephron Physiology;2014-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3